Results obtained in the LifEscozul™ Protocol in patient Mario Marín.
In this interview, for the LifEscozul Protocol™ (Escozul, blue scorpion venom, blue scorpion) we talk about Mario Marin, Mexico with his wife Marisela.
Mario Marín entered the LifEscozul™ Protocol in 2015. His diagnosis: EC III laryngeal cancer (invasive epidermoid carcinoma well differentiated in left vocal cord) with invasion to cricoid cartilage and involvement of pretracheal and paratracheal lymph nodes.
Upon entering the LifEscozul Protocol™ Mario was not well, he presented with pain in his throat and ears, reflux, vomiting, and a total loss of voice.
He was started on LifEscozul™ in May 2015. At this time the only solution proposed by the doctors was to remove the larynx, which was rejected by the patient. He started chemotherapy and radiotherapy in early July.
During the chemo and radiotherapy treatments, the patient's physical condition worsened, losing 20 kilograms of weight. After finishing them, his recovery was faster than expected, according to his doctor's opinion.
This interview was conducted by Biologist Ariel Portal for the Protocol LifEscozul™ (Escozul, blue scorpion venom, blue scorpion venom).
Mario was treated with LifEscozul™ (protein active ingredient) with periodic controls and progressive dose increases.
At the last biopsy performed in June 2016, Mario, presented only inflammation of the vocal cord.
For any questions please write to firstname.lastname@example.org or fill out the form.
The LifEscozul Group™ continues with this interview a cycle of interviews with our oldest patients within the LifEscozul Protocol™ ( Escozul, blue scorpion venom, blue scorpion).
LifEscozul™ is a product with a registered trademark in the USA and Ecuador and in the process of registration in more than 20 countries. It has been developed by Cuban doctors and scientists based on the antitumor active ingredient extracted from blue scorpion venom (Escozul).